Lung Pathology in Antiphospholipid Syndrome

Lung Pathology in Antiphospholipid Syndrome

Functional lesions of organs depend on the size of a diseased vessel and frequently require the use of intensive therapy methods. The commonest manifestation of antiphospholipid syndrome (APS) is deep vein thrombosis of the leg and pulmonary thromboembolism (PTE).Objective: to estimate the frequency...

Full description

Bibliographic Details
Main Authors:	T. M. Reshetnyak, S. G. Radenska-Lopovok, Ye. N. Aleksandrova, L. V. Kondratyeva, I. B. Shtivelband, A. A. Novikov, E. S. Mach, Ye. L. Nasonov
Format:	Article
Language:	English
Published:	Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2005-10-01
Series:	Общая реаниматология
Online Access:	https://www.reanimatology.com/rmt/article/view/1220

Similar Items

MARKERS OF INFLAMMATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND CARDIOVASCULAR PATHOLOGY
by: Nataliya Valer'evna Seredavkina, et al.
Published: (2010-10-01)

Varfarin in the complex treatment of antiphospholipid syndrome: preliminary results
by: T M Reshetnyak, et al.
Published: (2003-06-01)

Immunoglobuline administration in thrombocytopenia in patients with antiphospholipid syndrome
by: I. B. Shtivelband, et al.
Published: (2004-06-01)

Immunological markers of antiphospholipid syndrome. Part I – antiphospholipid antibodies
by: E N Alexandrova, et al.
Published: (2009-10-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
by: N V Seredavkina, et al.
Published: (2009-08-01)

Antiphospholipid syndrome, antiphospholipid antibodies and genetic thrombophilias in children TOC \o "1-5" \h \z with somatic pathology
by: T M Reshetnyak, et al.
Published: (2008-08-01)

PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

Aminoquinoline drugs in the treatment of systemic lupus erythematosus and antiphospholipid syndrome
by: L V Kondratyeva, et al.
Published: (2008-08-01)

Cytokines and neopterin in antiphospholipid syndrome
by: E N Alexandrova, et al.
Published: (2009-04-01)

Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up
by: T M Reshetnyak, et al.
Published: (2003-05-01)

Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome
by: N V Seredavkina, et al.
Published: (2008-06-01)

Aspirin in antiphospholipid syndrome
by: L V Kondratjeva, et al.
Published: (2005-08-01)

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: D V Reshetnyak, et al.
Published: (2004-05-01)

Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
by: Z S Alekberova, et al.
Published: (2004-08-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
by: I. A. Doroshkevich, et al.
Published: (2004-06-01)

Antiphospholipid syndrome and exogenic factors ofthromboses risk
by: E S Mach, et al.
Published: (2004-11-01)

Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)

Anxiety-depressive spectrum disorders in patients with obstetric antiphospholipid syndrome
by: A. B. Borisova, et al.
Published: (2024-12-01)

Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
by: Tatiana M. Reshetnyak, et al.
Published: (2022-06-01)

Thrombotic antiphospholipid syndrome: Recurrent thromboses
by: Tatiana M. Reshetnyak, et al.
Published: (2024-09-01)

Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future
by: Evgeny L. Nasonov, et al.
Published: (2023-07-01)

The antiphospholipid syndrome and the fibrinolytic system
by: Ekaterina Viktorovna Ostryakova, et al.
Published: (2011-12-01)

Mental disorders and cognitive impairment in patients with antiphospholipid syndrome
by: A. B. Borisova, et al.
Published: (2020-06-01)

Varfarin in the treatment of antiphospholipid syndrome
by: T M Reshetnyak
Published: (2003-04-01)

Risk factors and recurrent thrombosis in primary antiphospholipid syndrome
by: Fariza A. Cheldieva, et al.
Published: (2023-10-01)

Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01)

Recurrences of thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin
by: Lyubov' Valer'evna Kondrat'eva, et al.
Published: (2010-05-01)

Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome
by: G A Movsisyan, et al.
Published: (2017-09-01)

Current approaches to prevention and treatment of antiphospholipid syndrome
by: E L Nasonov
Published: (2003-05-01)

Aspergillosis in systemic lupus erythematosus
by: T. M. Reshetnyak, et al.
Published: (2016-05-01)

THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
by: E V Ostryakova, et al.
Published: (2012-05-01)

NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID SYNDROME
by: M. A. Satybaldyeva, et al.
Published: (2016-07-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

ANTIPHOSPHOLIPID SYNDROME: STATE-OF-THE-ART AND FUTURE TASKS
by: Tatiana Magomedalievna Reshetnyak
Published: (2013-02-01)

Laboratory diagnosis of antiphospholipid syndrome
by: E N Alexandrova, et al.
Published: (2004-08-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome
by: T M Reshetniak, et al.
Published: (2013-01-01)